GAPLINC and colorectal cancer: Besides, Yang et al. [14] found that colorectal cancer patients with GAPLINC high-expression had a shorter overall survival than those with GAPLINC low-expression, and high-expression of GAPLINC served as an independent unfavorable prognostic factor for overall survival in colorectal cancer patients.